Literature DB >> 28796836

Colonizing opportunistic pathogens (COPs): The beasts in all of us.

Lance B Price1,2, Bruce A Hungate3,4, Benjamin J Koch3,4, Gregg S Davis1, Cindy M Liu1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28796836      PMCID: PMC5552013          DOI: 10.1371/journal.ppat.1006369

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


× No keyword cloud information.

Introduction

Colonizing opportunistic pathogens (COPs) are microbes that asymptomatically colonize the human body and, when the conditions are right, can cause infections. Their ability to persist indefinitely and to be transmitted without detection [1] gives COPs a unique epidemiology that warrants special consideration. There are examples of COPs among bacteria, fungi (e.g., Candida albicans [2]), protozoa (e.g., Blastocystis [3, 4]), and viruses (e.g., Rhinovirus [5]), but bacterial COPs are of particular relevance because of their major contribution to today’s antibiotic resistance crisis. The COPs include a long list of notorious bacteria that live double lives as passive stowaways and virulent foes. Some of the best-known COPs include Staphylococcus aureus, extraintestinal pathogenic Escherichia coli (ExPEC), Klebsiella pneumoniae, and Streptococcus pneumoniae (Table 1). Their capacity for benign coexistence with humans belies their alter egos that exact a heavy burden of human disease. For example, in the United States, ExPEC bloodstream infections kill as many as 40,000 people annually [6], but, ExPEC are also benign colonizers in the gastrointestinal tract [7]. Host factors, including age, sex, health status, anatomy, and behavior, all play profound roles in infection susceptibility and severity [8-10]. In particular, immunocompromised individuals are at excess risk for infections caused by diverse bacteria, including COPs [11, 12] and even commensals. Yet, health status is not the sole determinant of infection by COPs. For example, healthy women more frequently suffer from urinary tract infections than men because of anatomical differences, including shorter urethrae. Likewise, healthy children more commonly suffer from acute otitis media than adults due to their shorter, flatter eustachian tubes [13].
Table 1

Common bacterial colonizing opportunistic pathogens, simple opportunistic pathogens, and frank pathogens.

COPsReservoir/Site of ColonizationAssociated Human Diseases
Staphylococcus aureusNasal cavity, skinCellulitis, abscesses, osteomyelitis, endocarditis, sepsis
Streptococcus pneumoniaeNasopharynxOtitis media, pneumonia, sepsis
ExPECOral cavity, skin, intestinal tractCystitis, pyelonephritis, meningitis, sepsis
Klebsiella pneumoniaeOral cavity, skin, intestinal tractCystitis, pneumonia, sepsis
SOPs
Vibrio vulnificusRaw/undercooked seafood, warm costal waterWound infection, hemorrhagic bullae, sepsis
Mycobacterium marinumContaminated water sources (e.g., untreated pools, fish aquaria)Granuloma, tenosynovitis, osteomyelitis
Legionella pneumophilaFreshwaters, contaminated human water systems (e.g., showers, faucets, cooling towers)Legionnaires’ disease, Pontiac fever
Frank pathogens
Escherichia coli 0157:H7Food animals, food productsBloody diarrhea, hemolytic uremic syndrome
Campylobacter jejuniFood animals, food productsWatery diarrhea, Guillain-Barre syndrome
Salmonella enterica (including S. typhi)Food animals, food productsGastroenteritis, cystitis, typhoid fever, sepsis
Mycobacterium tuberculosisLungs of infected patientsTuberculosis

COPs, colonizing opportunistic pathogens; ExPEC, extraintestinal pathogenic Escherichia coli; SOPs, simple opportunistic pathogens.

COPs, colonizing opportunistic pathogens; ExPEC, extraintestinal pathogenic Escherichia coli; SOPs, simple opportunistic pathogens. Here, we focus on the ecological features that distinguish COPs from other bacterial pathogens. We explore the public health implications that arise from their unique biology and discuss the research needed to illuminate the dynamics of COPs among their human, animal, and environmental reservoirs. And finally, we consider the commonalities among COPs that may require active monitoring and management. Our examination complements and extends the damage-response framework of pathogenesis proposed by Casadevall and Pirofski [14] without focusing on the pathogenicity or virulence potential of COPs, exploring specifically the host immune response, or delving into mechanisms of how COPs transition from colonization to infection.

COPs are a distinct subgroup of the opportunistic pathogens

The broad category of opportunistic pathogens can be divided into 2 distinct subgroups: the COPs and the noncolonizing, simple opportunistic pathogens (SOPs; Fig 1). The defining feature of all opportunistic pathogens is their capacity to cause disease when they are introduced into a susceptible body site or when hosts are immunologically compromised. The reservoirs of opportunistic pathogens are diverse and include food, water, soil, animals, and people with active infections. Whereas SOPs, such as Vibrio vulnificus, Mycobacterium marinum, and Legionella pneumophila, are only present in environmental reservoirs, COPs can also take up long-term residence in or on the human body as part of the “normal” human microbiome. For example, S. aureus can colonize the human nose asymptomatically and transmit from person-to-person without causing disease [15, 16]. Although COP colonization itself is asymptomatic, it can be an important risk factor for subsequent disease [17]. For S. aureus, higher-abundance colonization that is detectable by culture is further linked to higher risk of subsequent infection than lower-abundance colonization that is frequently undetected by culture [18].
Fig 1

Colonizing opportunistic pathogens (COPs) can persist asymptomatically and indefinitely within a host and may spread silently within the community.

These unique features of COPs result in epidemiological patterns distinct from those of frank pathogens and simple opportunistic pathogens (SOPs)—patterns that may have substantial public health consequences—such as the spread of antibiotic resistance. A deeper understanding of COP ecology is needed to reveal the reservoirs and transmission pathways of COPs and to design surveillance programs capable of detecting the otherwise invisible epidemics caused by COPs. (Illustration by Victor Leshyk.)

Colonizing opportunistic pathogens (COPs) can persist asymptomatically and indefinitely within a host and may spread silently within the community.

These unique features of COPs result in epidemiological patterns distinct from those of frank pathogens and simple opportunistic pathogens (SOPs)—patterns that may have substantial public health consequences—such as the spread of antibiotic resistance. A deeper understanding of COP ecology is needed to reveal the reservoirs and transmission pathways of COPs and to design surveillance programs capable of detecting the otherwise invisible epidemics caused by COPs. (Illustration by Victor Leshyk.) COPs differ from frank pathogens (Table 1), which can cause acute, chronic, or latent infections that can be symptomatic or asymptomatic [19]. While the latent and reactivation phases of frank pathogens, such as Mycobacterium tuberculosis and Salmonella enterica serovar Typhi, may mimic the colonization and infection phases of COPs, they are distinct in that these latent infections are typically preceded by an acute infection and maintenance of the latent phase requires an active adaptive immune response [20]. This is distinct from the fully asymptomatic colonization by COPs (Fig 1). The detection of frank pathogens is often associated with a diseased state, whether active or latent, and identifying cases of active or recent infections is usually enough to trace transmission routes. The well-characterized incubation periods of frank pathogens are consistent features of their epidemiology and aid in tracking infections [21]. In contrast, COPs lack predictable periods between colonization and infection, making their epidemiology cryptic. Because of this, COPs can cause insidious epidemics, where new clones transmit widely—even globally—among healthy populations before being recognized. For example, by the time ExPEC strain ST131 was discovered in 2008, it had already made its way to at least 3 continents [22].

COPs present a special challenge with respect to antibiotic resistance

Today, some of the most important multidrug-resistant bacterial pathogens—methicillin-resistant S. aureus (MRSA) and carbapenem-resistant Enterobacteriaceae—are COPs. Administration of an antibiotic exerts selective pressure on all bacterial populations within a host. As a result, antibiotics can select for antibiotic-resistant COPs, in addition to commensals within the host microbiome, regardless of whether or not the specific COP was the intended target of the antibiotic treatment. For example, 30% to 50% of healthy adults are carriers of S. aureus [17, 23, 24], and if a carrier takes a course of cephalosporins for an unrelated infection, the antibiotic is applying collateral selective pressure on the carrier’s S. aureus population, conferring advantage to resistant subpopulations, including MRSA. Resistant strains that surge under such selective pressure may persist long after the target infection is cleared; this is consistent with the finding that previous antibiotic use significantly increases the risk for future antibiotic-resistant infections [25-29]. Vaccination can also exert selective pressure on target species population, such as in the example of pneumococcal vaccine [30], in which the resultant serotype replacement has shifted the resistance profile seen among invasive S. pneumoniae infections [31].

Characterizing the ecology of COPs is paramount to understanding their epidemiology

Characterizing the ecology of COPs will require a new research framework beyond studies of virulence, antibiotic resistance, and epidemiology of individual species. Fully capturing the ecology of COPs will require studying their distribution and dynamics which span 17 orders of spatial magnitude—from the human microbiome (1x10-5 m) to global travel and commerce (5x1011m). This will require investigating the intra- and inter-species relationships that determine the success and duration of COP colonization, and also the roles of reservoirs (e.g., humans, animals, soil, water, air, and others) in the maintenance and transmission of COPs. Vegetable crops, meat products, water resources, and air can all potentially be contaminated by antibiotic-resistant COPs from food animals and animal wastes [32, 33], in which airborne exposure likely drives the link between proximity of residence to manure application and livestock operations to increased risk of community-acquired MRSA infections [34]. Such ambitious ecological studies may require species- and even strain- or clonal-level focus, but the collective lessons learned can inform how we monitor, forecast, and respond to COPs in general. The most urgent knowledge gaps related to COPs are the determinants of their colonization after exposure, the duration of colonization, and the transition from colonization to infection. Carefully designed observational studies could provide the samples necessary to close these knowledge gaps, given that empirical studies on human subjects may face ethical challenges, and that animal models—unless they are truly humanized in terms of immunity and resident microbiome—are likely to offer limited insight. Designing informative monitoring and observational studies will require creative and careful planning, as these knowledge gaps are well beyond the scope of typical studies conducted to date. One possible design encompassing the broad scale of COP ecology would be to monitor individuals from regions with a low prevalence of specific multidrug-resistant COPs that travel to regions where they are endemic [35]. One could then assess the microbiome and other host and microbial determinants of colonization and subsequent follow-up could provide insight into the transition from colonization to infection and human-to-human transmissions.

COPs require new active and integrative surveillance programs

Enhanced surveillance of COPs can enable public health agencies to identify and control emerging COP clones more quickly than is currently possible. Because of the insidious nature of COP epidemics, active surveillance programs that monitor both COPs circulating among asymptomatic carriers in the community and COPs causing clinical infections are crucial. This work will require the development of new molecular methods and could be integrated into existing surveillance programs, such as the National Healthcare and Safety Network, FoodNet, PulseNet, and the National Antimicrobial Resistance Monitoring System [36-39]. Active surveillance of COPs can involve sentinel communities, households, or individuals who are recruited to provide samples from body sites where COPs reside, such as nasal swabs and stool specimens for culture-based and molecular analyses. Current surveillance programs could expand their monitoring to encompass COP clones in clinical infections and in environmental reservoirs. Linking these data could allow an early warning system on emerging COP clones and provide valuable information for tracing community- versus healthcare-associated COP clones. Incorporating whole-genome DNA sequencing can further resolve subtleties ranging from shifts in COP clonal populations to the loss and gain of resistance-encoding mobile genetic elements [40-42]. Both frank pathogens and COPs can cause foodborne zoonotic infections. Infections caused by frank pathogens, such as Salmonella enterica, Campylobacter jejuni, and E. coli 0157:H7 (Table 1), can quickly be recognized and controlled by tracing clusters of infections to a common source [43-45]. Foodborne COPs, such as K. pneumoniae and multidrug-resistant ExPEC, are known to contaminate meat products and can cause infections in consumers [46]; however, because they may persist indefinitely in exposed hosts before causing an infection, disease clusters can be dispersed in time and space, obscuring the source of the pathogen. In addition to the prolonged colonization period, once a foodborne COP successfully colonizes a person, it may also be transmitted person-to-person [47], spreading through the human population to a far greater extent than frank foodborne pathogens. All of this contributes to the challenge of estimating the disease burden of foodborne COPs. A key target in active surveillance of COPs is the environmental reservoirs (e.g., air, food, and water) and nonhuman “co-host” species such as wild animals, companion animals, and livestock. The widespread use of antimicrobials in livestock [48] makes food animals an important target in monitoring novel resistance elements in COPs and emerging antibiotic-resistant COP clones—this is supported by the recent report of a mobile colistin-resistance element, mcr-1, among livestock in China [49]. We will need to monitor COPs throughout the livestock production system—from breeder farms to slaughter—to identify the origins and potential control points for emerging COPs from livestock. Other livestock products, such as wastes and meat, should be integrated into the active surveillance of COPs. Ideally, the active surveillance of environmental reservoirs should be coordinated with the sentinel community-based sites to maximize the integration across scales. “Sometimes, it tries to kid me that it's just a teddy bear or even somehow managed to vanish in the air and that is when I must beware of the beast in me.” The Beast in Me by Nick Lowe

Concluding thoughts

COPs are an important subgroup of the opportunistic pathogens that deserve special attention and require novel intervention strategies to curb their heavy public health burden. Understanding both the ecology and the epidemiology of COPs is necessary to identify effective interventions. Antimicrobial therapy is the current mainstay of treating COP infections, but the emergence of broadly multidrug-resistant COPs challenges this modality. The post-antibiotic era requires new ways to prevent COP infections by disrupting colonization rather than trying to treat pan-resistant infections. While much research will have to be conducted on the species or strain level, characterizing the full scope of COP ecology—from persistence in environmental reservoirs to transmission among humans—is key for taming these beasts in all of us.
  43 in total

1.  Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis.

Authors:  James R Johnson; Connie Clabots
Journal:  Clin Infect Dis       Date:  2006-10-10       Impact factor: 9.079

Review 2.  Common infections in kidney transplant recipients.

Authors:  Shamila Karuthu; Emily A Blumberg
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-13       Impact factor: 8.237

Review 3.  Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections.

Authors:  J A J W Kluytmans; H F L Wertheim
Journal:  Infection       Date:  2005-02       Impact factor: 3.553

4.  Chloramphenicol-resistant Salmonella newport traced through hamburger to dairy farms. A major persisting source of human salmonellosis in California.

Authors:  J S Spika; S H Waterman; G W Hoo; M E St Louis; R E Pacer; S M James; M L Bissett; L W Mayer; J Y Chiu; B Hall
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

5.  Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA.

Authors:  David P Calfee; Lisa J Durbin; Teresa P Germanson; Denise M Toney; Elise B Smith; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-06       Impact factor: 3.254

Review 6.  Blastocystis in Health and Disease: Are We Moving from a Clinical to a Public Health Perspective?

Authors:  Lee O'Brien Andersen; Christen Rune Stensvold
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

7.  Reclassification of Staphylococcus aureus nasal carriage types.

Authors:  Alex van Belkum; Nelianne J Verkaik; Corné P de Vogel; Hélène A Boelens; Jeroen Verveer; Jan L Nouwen; Henri A Verbrugh; Heiman F L Wertheim
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

Review 8.  Otitis media: diagnosis and treatment.

Authors:  Kathryn M Harmes; R Alexander Blackwood; Heather L Burrows; James M Cooke; R Van Harrison; Peter P Passamani
Journal:  Am Fam Physician       Date:  2013-10-01       Impact factor: 3.292

9.  The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Authors:  Lance B Price; James R Johnson; Maliha Aziz; Connie Clabots; Brian Johnston; Veronika Tchesnokova; Lora Nordstrom; Maria Billig; Sujay Chattopadhyay; Marc Stegger; Paal S Andersen; Talima Pearson; Kim Riddell; Peggy Rogers; Delia Scholes; Barbara Kahl; Paul Keim; Evgeni V Sokurenko
Journal:  mBio       Date:  2013-12-17       Impact factor: 7.867

Review 10.  The damage-response framework of microbial pathogenesis.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Nat Rev Microbiol       Date:  2003-10       Impact factor: 60.633

View more
  27 in total

1.  Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut Microbiota.

Authors:  Carola Venturini; Bethany Bowring; Alicia Fajardo-Lubian; Carol Devine; Jonathan Iredell
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

2.  16S rRNA Gene Sequence Identification of Cultivable-Bacterioplankton Between Ambient Water and Gastrointestinal Tract (GIT) of Resident Teleost.

Authors:  Patrick Senam Kofi Fatsi; Ebenezer Koranteng Appiah; Chogo Ogasawara; Pamela Afi Tettey; Shaharior Hashem; Hidetoshi Saito; Koichiro Kawai
Journal:  Indian J Microbiol       Date:  2021-11-15       Impact factor: 2.461

3.  Antibiotic Resistance in Pseudomonas.

Authors:  Pablo Laborda; Sara Hernando-Amado; José Luis Martínez; Fernando Sanz-García
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Mucosal microbial parasites/symbionts in health and disease: an integrative overview.

Authors:  Robert P Hirt
Journal:  Parasitology       Date:  2019-08       Impact factor: 3.234

Review 5.  Interplay of Human Gut Microbiome in Health and Wellness.

Authors:  Nirjara Singhvi; Vipin Gupta; Mohita Gaur; Vishal Sharma; Akshita Puri; Yogendra Singh; Gyanendra P Dubey; Rup Lal
Journal:  Indian J Microbiol       Date:  2019-09-05       Impact factor: 2.461

Review 6.  Defining and combating antibiotic resistance from One Health and Global Health perspectives.

Authors:  Sara Hernando-Amado; Teresa M Coque; Fernando Baquero; José L Martínez
Journal:  Nat Microbiol       Date:  2019-08-22       Impact factor: 17.745

Review 7.  Factors Obscuring the Role of E. coli from Domestic Animals in the Global Antimicrobial Resistance Crisis: An Evidence-Based Review.

Authors:  Fernanda Loayza; Jay P Graham; Gabriel Trueba
Journal:  Int J Environ Res Public Health       Date:  2020-04-28       Impact factor: 3.390

8.  Escherichia coli ST131-H22 as a Foodborne Uropathogen.

Authors:  Cindy M Liu; Marc Stegger; Maliha Aziz; Timothy J Johnson; Kara Waits; Lora Nordstrom; Lori Gauld; Brett Weaver; Diana Rolland; Sally Statham; Joseph Horwinski; Sanjeev Sariya; Gregg S Davis; Evgeni Sokurenko; Paul Keim; James R Johnson; Lance B Price
Journal:  MBio       Date:  2018-08-28       Impact factor: 7.867

9.  Diet in the Driving Seat: Natural Diet-Immunity-Microbiome Interactions in Wild Fish.

Authors:  Ida M Friberg; Joe D Taylor; Joseph A Jackson
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

10.  Phase Variation in HMW1A Controls a Phenotypic Switch in Haemophilus influenzae Associated with Pathoadaptation during Persistent Infection.

Authors:  Ariadna Fernández-Calvet; Begoña Euba; Celia Gil-Campillo; Arancha Catalan-Moreno; Javier Moleres; Sara Martí; Alexandra Merlos; Jeroen D Langereis; Francisco García-Del Portillo; Lauren O Bakaletz; Garth D Ehrlich; Eric A Porsch; Margarita Menéndez; Joshua C Mell; Alejandro Toledo-Arana; Junkal Garmendia
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.